Reyon Pharmaceutical Co., Ltd. (102460) Ratios

― Followers

Reyon Pharmaceutical Co., Ltd. Ratios

KR:102460's free cash flow for Q2 2026 was ₩0.23. For the 2026 fiscal year, KR:102460's free cash flow was decreased by ₩ and operating cash flow was ₩-0.20. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	0.50	0.56	0.66	0.79	2.27
Quick Ratio	0.26	0.29	0.35	0.51	1.65
Cash Ratio	0.04	0.05	0.08	0.19	0.33
Solvency Ratio	>-0.01	<0.01	0.04	0.03	0.05
Operating Cash Flow Ratio	0.04	<0.01	-0.01	0.07	0.18
Short-Term Operating Cash Flow Coverage	0.05	0.01	-0.02	0.09	0.39
Net Current Asset Value	₩ -170.96B	₩ -165.30B	₩ -160.61B	₩ -151.34B	₩ -127.92B
Leverage Ratios
Debt-to-Assets Ratio	0.49	0.46	0.41	0.45	0.43
Debt-to-Equity Ratio	1.11	0.98	0.82	0.91	0.85
Debt-to-Capital Ratio	0.53	0.50	0.45	0.48	0.46
Long-Term Debt-to-Capital Ratio	0.31	0.31	0.31	0.33	0.43
Financial Leverage Ratio	2.28	2.11	2.00	2.01	1.96
Debt Service Coverage Ratio	-0.12	-0.04	0.13	0.08	0.62
Interest Coverage Ratio	-2.18	-2.39	0.06	20.81	78.83
Debt to Market Cap	1.16	1.07	0.86	0.72	0.53
Interest Debt Per Share	12.57K	12.34K	11.19K	12.28K	11.85K
Net Debt to EBITDA	-13.99	918.23	15.19	22.30	14.36
Profitability Margins
Gross Profit Margin	21.48%	23.14%	49.08%	52.23%	53.06%
EBIT Margin	-33.04%	-21.63%	4.33%	2.80%	5.83%
EBITDA Margin	-10.46%	0.16%	8.60%	5.96%	8.78%
Operating Profit Margin	-20.96%	-21.63%	0.05%	2.67%	6.25%
Pretax Profit Margin	-22.50%	-16.90%	3.48%	2.67%	4.48%
Net Profit Margin	-24.02%	-20.44%	2.80%	2.37%	4.83%
Continuous Operations Profit Margin	-23.88%	-20.31%	2.80%	2.37%	4.83%
Net Income Per EBT	106.75%	120.91%	80.40%	88.87%	107.83%
EBT Per EBIT	107.33%	78.14%	6514.67%	99.96%	71.56%
Return on Assets (ROA)	-7.75%	-6.41%	0.83%	0.72%	1.53%
Return on Equity (ROE)	-16.06%	-13.55%	1.66%	1.44%	3.00%
Return on Capital Employed (ROCE)	-10.51%	-9.81%	0.02%	1.08%	2.21%
Return on Invested Capital (ROIC)	-7.28%	-7.20%	0.01%	0.75%	2.09%
Return on Tangible Assets	-7.81%	-6.47%	0.84%	0.72%	1.55%
Earnings Yield	-18.52%	-14.89%	1.76%	1.17%	1.91%
Efficiency Ratios
Receivables Turnover	4.13	4.21	4.01	3.78	3.61
Payables Turnover	14.64	12.95	7.53	9.07	15.09
Inventory Turnover	3.07	2.96	1.80	2.11	2.40
Fixed Asset Turnover	0.41	0.40	0.39	0.41	0.45
Asset Turnover	0.32	0.31	0.30	0.30	0.32
Working Capital Turnover Ratio	-1.90	-2.66	-4.13	8.57	1.73
Cash Conversion Cycle	182.28	181.99	245.48	229.14	228.95
Days of Sales Outstanding	88.28	86.74	90.99	96.47	101.16
Days of Inventory Outstanding	118.94	123.43	202.96	172.91	151.98
Days of Payables Outstanding	24.93	28.18	48.47	40.24	24.19
Operating Cycle	207.21	210.17	293.95	269.38	253.14
Cash Flow Ratios
Operating Cash Flow Per Share	324.45	66.12	-78.28	471.36	491.70
Free Cash Flow Per Share	49.40	-359.74	-951.89	-1.10K	-3.06K
CapEx Per Share	275.05	425.86	873.61	1.57K	3.56K
Free Cash Flow to Operating Cash Flow	0.15	-5.44	12.16	-2.34	-6.23
Dividend Paid and CapEx Coverage Ratio	1.18	0.16	-0.08	0.27	0.13
Capital Expenditure Coverage Ratio	1.18	0.16	-0.09	0.30	0.14
Operating Cash Flow Coverage Ratio	0.03	<0.01	>-0.01	0.04	0.04
Operating Cash Flow to Sales Ratio	0.04	<0.01	>-0.01	0.06	0.06
Free Cash Flow Yield	0.49%	-3.34%	-7.41%	-6.60%	-13.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-5.43	-6.72	56.73	85.48	52.42
Price-to-Sales (P/S) Ratio	1.30	1.37	1.59	2.03	2.53
Price-to-Book (P/B) Ratio	0.95	0.91	0.94	1.23	1.57
Price-to-Free Cash Flow (P/FCF) Ratio	205.27	-29.97	-13.49	-15.14	-7.16
Price-to-Operating Cash Flow Ratio	31.25	163.03	-164.02	35.43	44.64
Price-to-Earnings Growth (PEG) Ratio	0.05	<0.01	3.58	-1.62	1.47
Price-to-Fair Value	0.95	0.91	0.94	1.23	1.57
Enterprise Value Multiple	-26.39	1.80K	33.65	56.30	43.19
Enterprise Value	395.81B	409.82B	429.34B	507.24B	583.83B
EV to EBITDA	-26.39	1.80K	33.65	56.30	43.19
EV to Sales	2.76	2.81	2.90	3.36	3.79
EV to Free Cash Flow	436.87	-61.29	-24.59	-25.08	-10.73
EV to Operating Cash Flow	66.52	333.45	-299.02	58.67	66.88
Tangible Book Value Per Share	10.44K	11.61K	13.38K	13.48K	13.72K
Shareholders’ Equity Per Share	10.62K	11.84K	13.63K	13.56K	13.96K
Tax and Other Ratios
Effective Tax Rate	-0.06	-0.20	0.20	0.11	-0.08
Revenue Per Share	7.82K	7.85K	8.09K	8.24K	8.68K
Net Income Per Share	-1.88K	-1.60K	226.34	195.38	418.73
Tax Burden	1.07	1.21	0.80	0.89	1.08
Interest Burden	0.68	0.78	0.80	0.95	0.77
Research & Development to Revenue	0.03	0.03	0.02	0.06	0.04
SG&A to Revenue	0.26	0.21	0.22	0.21	0.24
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	-0.17	-0.04	-0.35	2.41	1.17

Currency in KRW